Abstract

IntroductionUwhangchungsimwon (UCW) is one of the most representative standardized herbal drugs for the treatment of central nervous system diseases, including mood disorders, and has been used for over 600 years in Korea and China. In spite of the long clinical application of UCW, no experimental evidence for its use against depressive disorders exists. Here, we performed an animal study to investigate the anti-depressive effect of UCW and the underlying mechanisms.MethodsA social isolation-induced depressive-like model was produced using C57BL/6J male mice by housing the mice individually for 31 days, and the mice underwent daily oral administration of distilled water, UCW (100, 200, 400 mg/kg) or fluoxetine (20 mg/kg) during the final 17 days. A tail suspension test (TST), forced swimming test (FST), and open field test (OFT) were used to explore the effects of UCW on depressive-like behaviors. 5-Hydroxytryptamine (5-HT) was measured in the dorsal raphe nuclei (DRN) using immunofluorescence. The serum corticosterone level was measured with its receptor and catecholamine, along with cAMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the hippocampus.ResultsSocial isolation stress effectively induced depressive-like behaviors, and UCW treatment significantly improved the symptoms of depressive-like behavior in the FST, TST, and OFT. The isolation stress-induced depletion of 5-HT was significantly ameliorated by UCW treatment. UCW also attenuated the activation of the glucocorticoid receptor (GR) and the elevated serum corticosterone level, as well as the hippocampal levels of dopamine and norepinephrine. Dexametasone-derived translocation of GR was inhibited by UCW treatment in PC12 cells and HT22 cells. In addition, alterations of tryptophan hydroxylase 2 (TPH2), BDNF, and CREB in the protein analyses were notably regulated by UCW treatment.ConclusionsThese results provide animal-based evidence for the anti-depressive effect of UCW, and its underlying mechanisms may involve regulating the serotonergic system, the hypothalamic-pituitary-adrenal (HPA) axis, and neurotrophin.

Highlights

  • Uwhangchungsimwon (UCW) is one of the most representative standardized herbal drugs for the treatment of central nervous system diseases, including mood disorders, and has been used for over 600 years in Korea and China

  • UCW was prepared based on the manufacturing process of the Ministry of Food and Drug Safety (MFDS) in Korea, and the contents of each ingredient were confirmed according to the quality control guidelines of the MFDS

  • As shown in Thin layer chromatography (TLC) analysis of UCW, all compositional herbs were verified in UCW (Supplementary Figure 2A)

Read more

Summary

Introduction

Uwhangchungsimwon (UCW) is one of the most representative standardized herbal drugs for the treatment of central nervous system diseases, including mood disorders, and has been used for over 600 years in Korea and China. We performed an animal study to investigate the antidepressive effect of UCW and the underlying mechanisms. The prevalence of depression was estimated at 4.4% in 2015, corresponding to approximately 322 million people worldwide. The estimated number of people suffering from depression between 2005 and 2015 increased by 18.4% (World Health Organization, 2017). Because of the multiple and complicated pathogenic factors involved in depression, the current antidepressants exhibit a narrow spectrum of activity and the limited effect (approximately 47% response rate and 28% remission rate) in the course of treatment among users (Gaynes et al, 2009; Duman et al, 2016). One review reported that exposure to SSRIs significantly increased the risk of suicide by approximately three-fold in children and adolescents (Barbui et al, 2009)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call